rec IGF-II (1-67) (human)

rec IGF-II (1-67) (human) comprises the N-terminal region of recombinant human IGF-II. The peptide includes core residues essential for receptor and binding-protein interactions. Researchers use it to explore folding intermediates, structural determinants, and comparative IGF signaling. Its sequence supports refined structural and biochemical analyses.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: I01009

CAS No:96081-16-2

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.W/Mr.
7469.46

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide CDMOPeptide Nucleic Acids SynthesisPeptide Synthesis ServicescGMP Peptide ServiceEpitope Mapping ServicesCustom Conjugation ServicePeptide Modification ServicesPeptide Analysis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers